The global cold agglutinin disease treatment market is experiencing a period of significant expansion. This phenomenon can be attributed to a confluence of factors, including an rising prevalence of cold agglutinin disease and advancements in treatment approaches. Major stakeholders in the market are actively researching in innovative treatments to